Artivion Inc. (AORT)
AORT trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/784199/000162828026009046/0001628280-26-009046-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | AORT on NYSE |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000784199 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $441.3M |
| Net income | $9.8M |
| Operating income | $33.7M |
| Net margin | 2.2% |
| Operating margin | 7.6% |
| Revenue growth | +13.6% |
| Cash | $64.9M |
| Total assets | $884.8M |
| P/E (computed) | 92.3× |
| P/S (computed) | 2.0× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-06 |
| Cash and burn | $48.4M cash; operating cash flow $3.7M a quarter. | Report 2026-09-30 |
| Shares outstanding | 48,789,772 (2026-10-30); 47,374,939 a year earlier; 41,048,608 three years earlier. | Cover page 2026-10-30 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Ernst & Young LLP, Atlanta, Georgia, United States | PCAOB Form AP 2026-03-04 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $20.4M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $123.8M | -$7.9M | -$4.6M | $48.4M | $363.8M | $481.9M | 10-Q 2026-11-06 |
| Q2 2026 2026-06-30 | $125.8M | -$13.5M | -$1.3M | $77.3M | $363.4M | $471.5M | 10-Q 2026-08-07 |
| Q1 2026 2026-03-31 | $116.3M | $1.4M | $1.2M | $55.8M | $215.4M | $458.7M | 10-Q 2026-05-08 |
| Q4 2025 2025-12-31 | $116.0M | $2.4M | $19.6M | $64.9M | $215.1M | $441.3M | 10-K 2026-02-18 |
| Q3 2025 2025-09-30 | $113.4M | $6.5M | $22.3M | $73.4M | $214.9M | $422.6M | 10-Q 2026-11-06 |
| Q2 2025 2025-06-30 | $113.0M | $1.3M | $15.0M | $53.5M | $215.6M | $405.0M | 10-Q 2026-08-07 |
| Q1 2025 2025-03-31 | $99.0M | -$505K | -$17.0M | $37.7M | $314.7M | $390.1M | 10-Q 2026-05-08 |
| Q4 2024 2024-12-31 | $97.3M | -$16.5M | $10.1M | $53.5M | $314.3M | $388.5M | 10-K 2026-02-18 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM S-3ASR | S-3ASR | 2024-03-01 |
| Latest annual report | 10-K | 2026-02-18 |
| Latest quarterly / interim | 10-Q | 2026-11-06 |
| Latest current report | 8-K | 2026-11-05 |
| Latest proxy ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS | DEFA14A | 2026-04-01 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -5.5% |
| 1 month | -10.6% |
| 3 months | -32.8% |
| Year to date | -58.1% |
| 1 year | -58.1% |
| From 52-week high | -59.5% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BVS | Bioventus Inc. | $10.46 | -1.88% | $881.4M |
| BBNX | Beta Bionics Inc. | $15.21 | -7.37% | $826.9M |
| KIDS | OrthoPediatrics Corp. | $31.50 | -2.63% | $822.5M |
| ATEC | Alphatec Holdings Inc. | $6.78 | -4.10% | $1.1B |
| SIBN | SI-BONE Inc. | $23.41 | -0.13% | $1.1B |
| SGP | SpyGlass Pharma Inc. | $32.24 | -1.95% | $1.1B |
| IRMD | iRadimed Corporation | $84.84 | -0.60% | $1.1B |
| IART | Integra LifeSciences Holdings Corporation | $13.98 | -2.92% | $1.1B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier